{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:34:58Z","timestamp":1770838498725,"version":"3.50.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Current treatment options for rosacea include topical agents, oral therapies, phototherapy using lasers, or intense pulsed light (IPL). Combination therapy for rosacea often yields better results than monotherapy. The safety of laser\/light treatments in combination with systemic doxycycline has been questioned because of the theoretical risk of photosensitivity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>The purpose of this study was to assess the incidence of phototoxicity or photosensitivity in rosacea patients receiving concomitant laser or light treatments and systemic doxycycline.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>Treatment records of 36 patients receiving laser\/light treatments while also being treated with standard dose or anti-inflammatory dose of doxycycline were retrospectively reviewed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>No adverse reactions related to doxycycline combined with laser\/light therapy were reported. Specifically, no photosensitivity or sensitivity to wavelengths in the pulsed dye laser (PDL), or IPL range was observed in this cohort. All patients achieved some degree of clearance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>The results of this retrospective study demonstrate that doxycycline used in conjunction with laser or nonlaser light therapy is a valid combination therapy for improving signs and symptoms of rosacea. No photosensitivity reactions were observed to commonly used IPL or PDL devices.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000002009","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T22:11:40Z","timestamp":1565302300000},"page":"1401-1405","source":"Crossref","is-referenced-by-count":15,"title":["Safety of Combination Laser or Intense Pulsed Light Therapies and Doxycycline for the Treatment of Rosacea"],"prefix":"10.1097","volume":"45","author":[{"given":"Laura M.","family":"Schilling","sequence":"first","affiliation":[{"name":"Maryland Laser Skin & Vein Institute, Hunt Valley, Maryland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian R.","family":"Halvorson","sequence":"additional","affiliation":[{"name":"Maryland Laser Skin & Vein Institute, Hunt Valley, Maryland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Maryland Laser Skin & Vein Institute, Hunt Valley, Maryland;"},{"name":"Department of Dermatology, University of Maryland School of Medicine, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret A.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Maryland Laser Skin & Vein Institute, Hunt Valley, Maryland;"},{"name":"Department of Dermatology, University of Maryland School of Medicine, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen L.","family":"Beasley","sequence":"additional","affiliation":[{"name":"Maryland Laser Skin & Vein Institute, Hunt Valley, Maryland;"},{"name":"Department of Dermatology, University of Maryland School of Medicine, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1468-3083.2005.01216.x","article-title":"Rosacea and its management: an overview","volume":"19","author":"Gupta","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaad.2014.08.028","article-title":"Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors","volume":"72","author":"Two","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jaad.2005.05.018","article-title":"Epidemiologic aspects of rosacea","volume":"53","author":"Kyriakis","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1540-9740.2003.03014.x","article-title":"Subantimicrobial dose doxycycline for acne and rosacea","volume":"2","author":"Bikowski","year":"2003","journal-title":"Skinmed"},{"key":"R5-20230814","first-page":"38","article-title":"What you should know about subantimicrobial dose doycycline","volume":"2","author":"Bikowski","year":"2007","journal-title":"Pract Dermatol"},{"issue":"3 Suppl","key":"R6-20230814","first-page":"17","article-title":"Reactive oxygen species and rosacea","volume":"74","author":"Jones","year":"2004","journal-title":"Cutis"},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2133.1986.tb02802.x","article-title":"Anti-oxidant action of metronidazole: a possible mechanism of action in rosacea","volume":"114","author":"Miyachi","year":"1986","journal-title":"Br J Dermatol"},{"issue":"4 Suppl","key":"R8-20230814","first-page":"6","article-title":"The anti-inflammatory effects of tetracyclines","volume":"75","author":"Weinberg","year":"2005","journal-title":"Cutis"},{"key":"R9-20230814","first-page":"251","article-title":"Rosacea: where are we now?","volume":"3","author":"Bikowski","year":"2004","journal-title":"J Drugs Dermatol"},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12019-007-8003-x","article-title":"Submicrobial doxycycline and rosacea","volume":"33","author":"Wise","year":"2007","journal-title":"Compr Ther"},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2006.11.021","article-title":"Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea","volume":"56","author":"Del Rosso","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R12-20230814","first-page":"118","article-title":"A status report on the use of subantimicrobial-dose doxycycline: a review of the biologic and antimicrobial effects of the tetracyclines","volume":"74","author":"Del Rosso","year":"2004","journal-title":"Cutis"},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/00042728-200510000-00004","article-title":"Effective treatment of rosacea using intense pulsed light systems","volume":"31","author":"Schroeter","year":"2005","journal-title":"Dermatol Surg"},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/14628839950516922","article-title":"Treatment of facial vascular lesions with intense pulsed light","volume":"1","author":"Angermeier","year":"1999","journal-title":"J Cutan Laser Ther"},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1473-2165.2005.00202.x","article-title":"A retrospective study of the efficacy of intense pulsed light for the treatment of dermatologic disorders presenting to a cosmetic skin clinic","volume":"4","author":"Myers","year":"2005","journal-title":"J Cosmet Dermatol"},{"key":"R16-20230814","first-page":"449","article-title":"Objective evaluation of the effect of intense pulsed light on rosacea and solar lentigines by spectrophotometric analysis of skin color","volume":"33","author":"Kawana","year":"2007","journal-title":"Dermatol Surg"},{"issue":"5 Suppl","key":"R17-20230814","first-page":"S4","article-title":"Combination therapy in clinical and cosmetic dermatology: the marriage of device and drug","volume":"3","author":"Nestor","year":"2004","journal-title":"J Drugs Dermatol"},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/lsm.20621","article-title":"Rosacea treatment using the new-generation, high-energy, 595 nm, long pulse-duration pulsed-dye laser","volume":"40","author":"Bernstein","year":"2008","journal-title":"Lasers Surg Med"},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jaad.2015.05.030","article-title":"Efficacy of the long-pulsed 1064-nm neodymium:yttrium-aluminum-garnet laser (LPND) (rejuvenation mode) in the treatment of papulopustular rosacea (PPR): a pilot study of clinical outcomes and patient satisfaction in 30 cases","volume":"73","author":"Lee","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s10103-014-1553-0","article-title":"Laser therapy and photosensitive medication: a review of the evidence","volume":"29","author":"Kerstein","year":"2014","journal-title":"Lasers Med Sci"},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000458761","article-title":"Phototoxicity of doxycycline: a systematic review on clinical manifestations, frequency, cofactors, and prevention","volume":"30","author":"Goetze","year":"2017","journal-title":"Skin Pharmacol Physiol"},{"key":"R22-20230814","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/1523-1747.ep12263531","article-title":"Mechanism of tetracycline phototoxicity","volume":"83","author":"Hasan","year":"1984","journal-title":"J Invest Dermatol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T19:38:55Z","timestamp":1692041935000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000002009","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}